TrialEuropean journal of clinical pharmacology2022

The effect of potent CYP2D6 inhibition on the pharmacokinetics and safety of deutetrabenazine in healthy volunteers.

F Schneider et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.